Pleuratech Overview

  • Founded
  • 2010
Founded
  • Status
  • Private
  • Latest Deal Type
  • Accelerator/​Inc
  • Investors
  • 6

Pleuratech General Information

Description

Developer of surgical tools designed to use for the treatment of collapsed lung situations. The company's tools promote safe and accurate insertion and placement of pleural drains, enabling surgeons to place the chest drain correctly in an easy way for a good recovery.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Surgical Devices
Primary Office
  • Brendstrupgaardsvej 102
  • 8200 Aarhus
  • Denmark
+45 40 00 00 00
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Pleuratech Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Accelerator/Incubator Completed Clinical Trials - General
3. Accelerator/Incubator 000.00 Completed Clinical Trials - General
2. Early Stage VC 01-Jan-2010 Completed Startup
1. Grant Completed Startup
To view Pleuratech’s complete valuation and funding history, request access »

Pleuratech Executive Team (2)

Name Title Board Seat Contact Info
Niels Katballe Ph.D Co-Founder
Peter Heydorn Co-Founder
To view Pleuratech’s complete executive team members history, request access »

Pleuratech Board Members (1)

Name Representing Role Since
Jørn Falch MD Capnova Board Member 000 0000
To view Pleuratech’s complete board members history, request access »

Pleuratech Investors (6)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Aarhus University Research Foundation Corporation Minority 000 0000 000000 0
Capnova Venture Capital Minority 000 0000 000000 0
J&B Investments Other Minority 000 0000 000000 0
Danish Ministry of Research, Innovation and Superior Education Government 000 0000 000000 0
INCUBA Accelerator/Incubator Minority 000 0000 000000 0
You’re viewing 5 of 6 investors. Get the full list »